Showing 821-830 of 18562 results for "".
Natural History of Breast Cancer: Early Detection vs. Mortality
https://reachmd.com/programs/focus-on-cancer/natural-history-of-breast-cancer-early-detection-vs-mortality/4319/The widespread use of mammography to screen for breast cancer has resulted in a decrease in breast tumor detection, as well as decrease in mortality rates associated with the disease. But the natural course of malignant diseases such as different types of cancer can vary considerably. Is it possibleSpotlight on Systemic Sclerosis: Pathophysiology, Presentation, & Emerging Evidence
https://reachmd.com/programs/cme/spotlight-on-systemic-sclerosis-pathophysiology-presentation-emerging-evidence/48716/Systemic sclerosis (SSc) is complex and often diagnosed late. Explore the vasculopathy-fibrosis axis as a key driver of disease progression and clinical manifestations. Learn to recognize phenotypic red flags for ILD, PAH, and renal crisis, and apply risk stratification strategies to guide earlier iLH vs hCG: Formulations and Physiological Differences
https://reachmd.com/programs/global-womens-health-academy/lh-vs-hcg-formulations-and-physiological-differences/9556/Join Dr. Sandro Esteves in this excerpt of his live presentation entitled LH vs. hCG: Formulations and Physiological Differences, delivered during EXCEMED’s First World Conference on Luteinizing Hormone in ART: Landing in Latin America held in Mexico City, Mexico on 7 April 2017. This presentation iImmunotherapy for Management of Refractory and Super-Refractory Status Epilepticus
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/immunotherapy-for-management-of-refractory-and-super-refractory-status-epilepticus/39948/This review explores the role of neuroinflammation in refractory and super-refractory status epilepticus, as well as the role of therapeutic immunomodulation in their management.Closing the Gap to Care: Assessing CAD and Improving Patient Outcomes with Revascularization
https://reachmd.com/programs/cme/closing-the-gap-to-care-assessing-cad-and-improving-patient-outcomes-with-revascularization/14855/Are we really doing our best to assess CAD in our patients? Experts discuss ways to close gaps in care and improve patient outcomes.Collaborative Insights to Solve the Puzzle of Bladder Cancer
https://reachmd.com/programs/cme/collaborative-insights-to-solve-the-puzzle-of-bladder-cancer/30062/Our experts provide vital education on the latest clinical insights and molecular targets advancing personalized care in bladder cancer.Dr. Dean Ornish, President of the Preventive Medicine Research Institute
https://reachmd.com/programs/conversations-on-health-care/dr-dean-ornish-president-preventive-medicine-research-institute/7939/This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Dean Ornish, Founder and President of the Preventive Medicine Research Institute. He analyzes the new USDA nutritional guidelines and discusses the mounting empirical evidence linking sound nutrition and integrative medicine to the pEpilepsy Essentials: Novel Interictal Biomarkers for Delineating the Epileptogenic Zone in Children With Drug-Resistant Epilepsy
https://reachmd.com/programs/practical-neurology-focus-on-epilepsy-seizures/epilepsy-essentials-novel-interictal-biomarkers-for-delineating-the-epileptogenic-zone-in-children-with-drug-resistant-epilepsy/32147/Novel interictal biomarkers of epilepsy are able to identify the epileptogenic zone with precision and predict surgical outcome in children with drug-resistant epilepsy.Non-Stimulant Options for ADHD Patients
https://reachmd.com/programs/focus-on-neurology-and-psychiatry/non-stimulant-options-for-adhd-patients/4383/Although stimulant medications are often used to treat ADHD patients, there are patients for whom non-stimulants might also be a viable option. What are the advantages to each type of medication? Dr. Richard Rubin, clinical associate professor at the University of Vermont College of Medicine and adjThe Genetics of Migraine: Advancing Diagnosis and Personalizing Treatment
https://reachmd.com/programs/frontlines-migraine/the-genetics-of-migraine-advancing-diagnosis-and-personalizing-treatment/36156/Decades of research have transformed our understanding of migraine genetics, from rare monogenic types to complex polygenic forms. Mr. Ryan Quigley is joined by Dr. Lyn Griffiths to explore polygenic risk scores, emerging diagnostic tools, and the promise of personalized medicine in migraine